Small Cell Lung Cancer ( SCLC ) Clinical Trials in Duarte, California

3 studies are recruiting for small cell lung cancer ( sclc ) in Duarte, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

    The purpose of this study is to learn about the safety and effects of the study medicine (called Mevrometostat) for the possible treatment of Relapsed/ Refractory Small Cell Lung Cancer (SCLC), Castration Resistant Prostate Cancer (CRPC) and Follicular Lymphoma (FL). The study consists of 3 parts; …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte, California
    Locations
    84 in total
    Run by
    Pfizer

    See if you can join NCT03460977 on ClinicalTrials.gov

  2. Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

    This study is being done to learn more about a new medicine called PF-08634404. The study team wants to understand how well PF-08634404 works when given alone or with chemotherapy . Chemotherapy is a type of cancer treatment that uses medicines to destroy cancer cells or stop them from growing. The…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    City of Hope National Medical Center, Duarte, California
    Locations
    30 in total
    Run by
    Pfizer

    See if you can join NCT07476287 on ClinicalTrials.gov

  3. A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

    This is a first-in-human, Phase 1/2, open-label, dose escalation, dose expansion and combination study designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of Peluntamig (PT217) as a monotherapy and in combination with chemotherapy.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte, California
    Locations
    15 in total
    Run by
    Phanes Therapeutics

    See if you can join NCT05652686 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.